2016
DOI: 10.1371/journal.pcbi.1005187
|View full text |Cite
|
Sign up to set email alerts
|

MinePath: Mining for Phenotype Differential Sub-paths in Molecular Pathways

Abstract: Pathway analysis methodologies couple traditional gene expression analysis with knowledge encoded in established molecular pathway networks, offering a promising approach towards the biological interpretation of phenotype differentiating genes. Early pathway analysis methodologies, named as gene set analysis (GSA), view pathways just as plain lists of genes without taking into account either the underlying pathway network topology or the involved gene regulatory relations. These approaches, even if they achiev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
3
1

Relationship

4
4

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 134 publications
0
14
0
Order By: Relevance
“…The results contain phenotype discriminant pathways and sub-paths, which are passed to the MinePath Viewer for visualization and exploration of regulatory mechanisms. A detailed description of the methodology and thorough validation of the algorithm using various independent train and test datasets, including microarray and RNA-seq expression data, can be found in ( 20 ).…”
Section: Methodsmentioning
confidence: 99%
“…The results contain phenotype discriminant pathways and sub-paths, which are passed to the MinePath Viewer for visualization and exploration of regulatory mechanisms. A detailed description of the methodology and thorough validation of the algorithm using various independent train and test datasets, including microarray and RNA-seq expression data, can be found in ( 20 ).…”
Section: Methodsmentioning
confidence: 99%
“…the St. Gallen risk model) and knowledge models from relevant research (e.g. Oncosimulator [56], MinePath [57], microRNA model [58]) in the oncology domain. Fig.…”
Section: The Decision Support Toolmentioning
confidence: 99%
“…Access to external biobanks can be established and freely available data from the web can be stored in the data warehouse with the aid of literature mining (Potamias et al 2005). Depending on the scenario, users are able to execute models (Sfakianakis et al 2009), use the p-medicine Oncosimulator (Stamatakos et al 2014), systems biology models (Koumakis et al 2016a;Koumakis et al 2017;Mehta et al 2016) or they can use the Decision Support System . In all cases results lead to personalized medicine via decision support.…”
Section: P-medicinementioning
confidence: 99%